Sangre BioSciences is currently in the process of conducting a comprehensive Cannabis Genome Study to complete a global genomic classification of the cannabis plant genus. Sangre BioSciences is focused on a genomics based cannabis breeding program that will produce new, genetically enhanced strains of cannabis that express the desired plant characteristics for strain specific and disease specific treatments and therapies for both humans and animals.
Be the first to receive the latest Industry and WEED INC. News & Updates.
Weed Australia Ltd.
WEED Israel Cannabis Ltd.
The Hemp Institute of Arizona
The Cannabis Institute of Australia